Most cited papers from CardioDx (United States)

CardioDx (United States)

What are the most cited papers from CardioDx (United States)?

The most cited paper from CardioDx (United States) is "Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease" (Wei Zhao et al., 2017), with 300 citations. Next come "Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis" (205) and "Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients" (176).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 52 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease Wei Zhao et al. · Nature Genetics Open access	4 Sep 2017	300
2	Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis James A. Wingrove, Susan E. Daniels, Amy J. Sehnert et al. · Circulation Cardiovascular Genetics	Oct 2008	205
3	Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients Steven J. Rosenberg et al. · Annals of Internal Medicine Open access	5 Oct 2010	176
4	Prefrontal GABAA receptor α-subunit expression in normal postnatal human development and schizophrenia Carlotta E. Duncan, Maree J. Webster, Debora A. Rothmond et al. · Journal of Psychiatric Research	26 Jan 2010	172
5	Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients Michael R. Elashoff, James A. Wingrove, Philip Beineke et al. · BMC Medical Genomics Open access	28 Mar 2011	145
6	Lack of Association Between Adrenergic Receptor Genotypes and Survival in Heart Failure Patients Treated With Carvedilol or Metoprolol Amy J. Sehnert, Susan E. Daniels, Michael R. Elashoff et al. · Journal of the American College of Cardiology Open access	24 Jun 2008	126
7	Mitochondrial DNA Variants of Respiratory Complex I that Uniquely Characterize Haplogroup T2 Are Associated with Increased Risk of Age-Related Macular Degeneration John Paul SanGiovanni, Dan E. Arking, Sudha K. Iyengar et al. · PLoS ONE Open access	11 May 2009	101
8	A whole blood gene expression-based signature for smoking status Philip Beineke, Karen R. Fitch, Heng Tao et al. · BMC Medical Genomics Open access	Dec 2012	93
9	A genome‐wide association study suggests new evidence for an association of the NADPH Oxidase 4 ( NOX 4) gene with severe diabetic retinopathy in type 2 diabetes Weihua Meng et al. · Acta Ophthalmologica Open access	4 Sep 2018	82
10	A Blood-Based Gene Expression Test for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging The COMPASS Study Gregory S. Thomas, Szilárd Vörös, John McPherson et al. · Circulation Cardiovascular Genetics	16 Feb 2013	73
11	Preventing tomorrow's sudden cardiac death today Sana M. Al‐Khatib, Gillian D Sanders, Mark D. Carlson et al. · American Heart Journal	27 Jul 2008	48
12	Developmental co‐regulation of the β and γ GABAAreceptor subunits with distinct α subunits in the human dorsolateral prefrontal cortex Stu G. Fillman, Carlotta E. Duncan, Maree J. Webster et al. · International Journal of Developmental Neuroscience	4 Jun 2010	44
13	Clinical Implications of Referral Bias in the Diagnostic Performance of Exercise Testing for Coronary Artery Disease Joseph A. Ladapo, Saul Blecker, Michael R. Elashoff et al. · Journal of the American Heart Association Open access	18 Nov 2013	41
14	Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug‐induced torsades de pointes Philip T. Sager · British Journal of Pharmacology Open access	9 Jun 2008	40
15	Apoprotein B, Small‐Dense LDL and Impaired HDL Remodeling Is Associated With Larger Plaque Burden and More Noncalcified Plaque as Assessed by Coronary CT Angiography and Intravascular Ultrasound With Radiofrequency Backscatter: Results From the ATLANTA I Study Szilárd Vörös, Parag H. Joshi, Zhen Qian et al. · Journal of the American Heart Association Open access	18 Nov 2013	33
16	Use of the Corus® CAD Gene Expression Test for Assessment of Obstructive Coronary Artery Disease Likelihood in Symptomatic Non-Diabetic Patients Jose D. Vargas, João A.C. Lima, William E. Kraus et al. · PLoS Currents Open access	2013	28
17	A peripheral blood gene expression score is associated with atherosclerotic Plaque Burden and Stenosis by cardiovascular CT-angiography Szilárd Vörös, Michael R. Elashoff, James A. Wingrove et al. · Atherosclerosis Open access	20 Jan 2014	27
18	Whole Blood Gene Expression Testing for Coronary Artery Disease in Nondiabetic Patients: Major Adverse Cardiovascular Events and Interventions in the PREDICT Trial for the PREDICT Investigators, Steven J. Rosenberg, Michael R. Elashoff et al. · Journal of Cardiovascular Translational Research Open access	6 Mar 2012	26
19	Coronary Atherosclerotic Plaque Detected by Computed Tomographic Angiography in Subjects with Diabetes Compared to Those without Diabetes Bahram Khazai, Yanting Luo, Steven J. Rosenberg et al. · PLoS ONE Open access	23 Nov 2015	24
20	Genetically Determined Plasma Lipid Levels and Risk of Diabetic Retinopathy: A Mendelian Randomization Study Lucia Sobrin et al. · Diabetes Open access149 authors	26 Sep 2017	20
21	Identification of Factors Contributing to Variability in a Blood-Based Gene Expression Test Michael R. Elashoff, Rachel Nuttall, Philip Beineke et al. · PLoS ONE Open access	3 Jul 2012	19
22	Utility of a Genomic-based, Personalized Medicine Test in Patients Presenting With Symptoms Suggesting Coronary Artery Disease Levente Hermán, James Froelich, Dino Kanelos et al. · The Journal of the American Board of Family Medicine Open access	Mar 2014	18
23	Early clinical development: Evaluation of drug-induced torsades de pointes risk Torbjörn Vik, Chris E. Pollard, Philip T. Sager · Pharmacology & Therapeutics	14 Jun 2008	18
24	Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery Disease Joseph A. Ladapo, Matthew Jay Budoff, David Sharp et al. · The American Journal of Medicine Open access	16 Dec 2016	15
25	An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial Deepak Voora, Adrian Coles, Kerry L. Lee et al. · American Heart Journal Open access	15 Nov 2016	15
26	Biological and Analytical Stability of a Peripheral Blood Gene Expression Score for Obstructive Coronary Artery Disease in the PREDICT and COMPASS Studies Susan E. Daniels, Philip Beineke, Brian K. Rhees et al. · Journal of Cardiovascular Translational Research Open access	13 Aug 2014	13
27	Rheumatoid arthritis complicates noninvasive whole blood gene expression testing for coronary artery disease Ryan C. Jessee, Erica Peart, Phil Beineke et al. · American Heart Journal	2 Jul 2017	12
28	Economic Utility of a Blood-Based Genomic Test for the Assessment of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease Louis I. Hochheiser, Jessie L. Juusola, Mark Monane et al. · Population Health Management Open access	25 Feb 2014	9
29	Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events James A. Wingrove, Karen R. Fitch, Brian K. Rhees et al. · BMC Medical Genomics Open access	12 Jan 2018	7
30	Use of a blood test incorporating age, sex, and gene expression influences medical decision-making in the evaluation of women presenting with symptoms suggestive of obstructive coronary artery disease Joseph A. Ladapo, Lee H. Herman, Bonnie H. Weiner et al. · Menopause The Journal of The North American Menopause Society	3 Apr 2015	7
31	QT/QTc Prolongation in Placebo-Treated Subjects: a PhRMA Collaborative Data Analysis Marilyn A. Agin, William S. Aronstein, Georg Ferber et al. · Journal of Biopharmaceutical Statistics	8 May 2008	7
32	Developing Peripheral Blood Gene Expression-Based Diagnostic Tests for Coronary Artery Disease: a Review Brian K. Rhees, James A. Wingrove · Journal of Cardiovascular Translational Research	24 Jun 2015	7
33	Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients Xi Wang, Brian Z. Ring, Robert S. Seitz et al. · BMC Clinical Pathology Open access	Dec 2015	6
34	Enhanced Assessment of Chest Pain and Related Symptoms in the Primary Care Setting Through the Use of a Novel Personalized Medicine Genomic Test Joseph A. Ladapo, Heather A. Lyons, May Yau et al. · American Journal of Medical Quality	5 May 2014	6
35	Utility of a Precision Medicine Test in Elderly Adults with Symptoms Suggestive of Coronary Artery Disease Joseph A. Ladapo, Matthew Jay Budoff, David Sharp et al. · Journal of the American Geriatrics Society Open access	6 Dec 2017	5
36	The Diagnosis of CAD in Women: Addressing the Unmet Need—A Report from the National Expert Roundtable Meeting Janice L. Clarke, Joseph L. Ladapo, Mark Monane et al. · Population Health Management Open access	25 Feb 2015	5
37	Evaluation of a solid matrix for collection and ambient storage of RNA from whole blood Heng Tao, Philip Beineke, Bing Li et al. · BMC Clinical Pathology Open access	13 May 2014	4
38	Economic Outcomes of a Precision Medicine Blood Test To Assess Obstructive Coronary Artery Disease: Results from the PRESET Registry. Joseph A. Ladapo, Matthew Jay Budoff, Pejman Azarmina et al. · PubMed Open access	Jun 2018	2
39	The Clinical Utility of a Precision Medicine Blood Test Incorporating Age, Sex, and Gene Expression for Evaluating Women with Stable Symptoms Suggestive of Obstructive Coronary Artery Disease: Analysis from the PRESET Registry Burcu Gül, Alexandra J. Lansky, Matthew Jay Budoff et al. · Journal of Women s Health Open access	17 Jan 2019	2
40	Role of Statistics in Toxicogenomics Michael R. Elashoff · Methods in molecular biology Book chapter	2008	1
41	Cost effectiveness in palliative care setting Henry O’Lawrence, Rohan Chowlkar · International Journal of Organization Theory and Behavior	24 Apr 2018	0
42	Novel Approaches to Cardiovascular Diagnostics James A. Wingrove, Steven J. Rosenberg · Elsevier eBooks Book chapter	29 Nov 2017	0
43	THE USE OF A GENE EXPRESSION SCORE WAS ASSOCIATED WITH IMPROVED MEDICAL DECISION MAKING IN THE EVALUATION OF WOMEN PRESENTING WITH SYMPTOMS SUGGESTIVE OF OBSTRUCTIVE CORONARY ARTERY DISEASE: SUMMARY RESULTS FROM TWO AMBULATORY CARE STUDIES IN PRIMARY CARE Joseph A. Ladapo, Lee H. Herman, Bonnie H. Weiner et al. · Journal of the American College of Cardiology Open access	Mar 2015	0
44	Transcriptional Signatures, Imaging, and Coronary Artery Disease Diagnosis Steven J. Rosenberg · Journal of Cardiovascular Translational Research Open access	13 May 2015	0
45	Use Of A Blood-Based Gene Expression Score Was Associated With Lower Diagnostic Testing Costs In Patients Presenting To The Cardiologist With Symptoms Suggestive Of Obstructive Coronary Artery Disease: An Economic Analysis Of The Impact-Card (Investigation Of A Molecular Personalized Coronary Gene Expression Test On Cardiology Practice Pattern) Trial John McPherson, May Yau, Jessie L. Juusola et al. · Value in Health Open access	May 2014	0
46	Percutaneous Intraventricular Device for Treatment of Heart Failure: Experimental Results Serjan D. Nikolic, Alex Khairkhahan, Gerard L. Champsaur et al. · Journal of Cardiac Failure	30 Jul 2008	0
47	GENE EXPRESSION SCORES FOR CAD ARE STABLE OVER ONE YEAR: RESULTS FROM THE COMPASS TRIAL Gregory S. Thomas, John McPherson, Brian K. Rhees et al. · Journal of the American College of Cardiology Open access	27 Mar 2014	0
48	A NOVEL BLOOD-BASED GENE EXPRESSION SIGNATURE FOR SMOKING STATUS IS SIGNIFICANTLY ASSOCIATED WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS IN THE PREDICT TRIAL James A. Wingrove, Brian K. Rhees, Phil Beineke et al. · Journal of the American College of Cardiology Open access	27 Mar 2014	0
49	A PERIPHERAL BLOOD GENE EXPRESSION SCORE FOR CORONARY ARTERY DISEASE IN NON-DIABETIC PATIENTS IDENTIFIES PATIENTS AT LOW RISK FOR MAJOR CARDIOVASCULAR EVENTS AND INTERVENTIONAL PROCEDURES IN THE NEXT 12 MONTHS William E. Kraus, Szilárd Vörös, Robert S. Schwartz et al. · Journal of the American College of Cardiology Open access	Mar 2012	0
50	A PREVIOUSLY VALIDATED PERIPHERAL GENE EXPRESSION SCORE IS MOSTLY DETERMINED BY NON-CALCIFIED PLAQUE AND LUMINAL STENOSIS AS ASSESSED BY QUANTITATIVE, 3-DIMENSIONAL MEASUREMENTS BY CT ANGIOGRAPHY IN THE MULTI-CENTER, PROSPECTIVE COMPASS STUDY Szilárd Vörös, Gregory Thomas, Alexandra J. Lansky et al. · Journal of the American College of Cardiology Open access	Mar 2012	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.